. 2018 May 4;2(4):e45. doi: 10.1097/HS9.0000000000000045
Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.
This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
Table 4.
Overall Survival in Patients Initiating a Line of Treatment During 2008 to 2013, by Subgroup
